English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  52882035    線上人數 :  686
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"hsu c"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 266-290 / 881 (共36頁)
<< < 6 7 8 9 10 11 12 13 14 15 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-08-10T03:53:07Z Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trials SHIH-HUNG YANG; Kuo Y.-H.; Tien Y.-W.; Hsu C.; Hsu C.-H.; Kuo S.-H.; Cheng A.-L.
臺大學術典藏 2021-08-10T03:53:06Z Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy Kuo Y.-H.; Lin C.-H.; Shau W.-Y.; Chen T.-J.; SHIH-HUNG YANG; Huang S.-M.; Hsu C.; Lu Y.-S.; Cheng A.-L.
臺大學術典藏 2021-08-10T03:53:04Z Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer SHIH-HUNG YANG; Kuo T.-C.; Wu H.; Guo J.-C.; Hsu C.; Hsu C.-H.; Tien Y.-W.; Yeh K.-H.; Cheng A.-L.; Kuo S.-H.
臺大學術典藏 2021-08-10T03:53:01Z A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma�VTCOG T1211 study Chiang N.-J.; Tsai K.K.; Hsiao C.-F.; SHIH-HUNG YANG; Hsiao H.-H.; Shen W.-C.; Hsu C.; Lin Y.-L.; Chen J.-S.; Shan Y.-S.; Chen L.-T.
臺大學術典藏 2021-08-10T03:53:01Z Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patients SHIH-HUNG YANG; Guo J.-C.; Hsu C.; Kuo S.-H.; Tien Y.-W.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2021-08-10T03:53:00Z Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study Chiang N.-J.; Chen M.-H.; SHIH-HUNG YANG; Hsu C.; Yen C.-J.; Tsou H.-H.; Su Y.-Y.; Chen J.-S.; Shan Y.-S.; Chen L.-T.
臺大學術典藏 2021-08-05T02:37:30Z Study on the transient response to the point-to-point motion controls on a dual-axes air-bearing planar stage Kuo F.-C;Hsu C;Hsieh M.-R;Yen J.-Y;Chen L.-C;Chung T.-T;Wang F.-C.; Kuo F.-C; Hsu C; Hsieh M.-R; Yen J.-Y; Chen L.-C; Chung T.-T; Wang F.-C.; LIANG-CHIA CHEN
臺大學術典藏 2021-08-03T07:10:54Z Potential of circulating immune cells as biomarkers of nivolumab treatment efficacy for advanced hepatocellular carcinoma Hung Y.-P.; YU-YUN SHAO; Lee J.-M.; Hsu C.; Hsu C.-H.; Yang M.-H.; Chao Y.
臺大學術典藏 2021-08-03T07:10:53Z Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan YU-YUN SHAO; Wang S.-Y.; Lin S.-M.; Chen K.-Y.; Tseng J.-H.; Ho M.-C.; Lee R.-C.; Liang P.-C.; Liao L.-Y.; Huang K.-W.; Hu J.-T.; Liang J.-D.; Kee K.-M.; Lin C.-L.; Wang C.-K.; Lu S.-N.; Wang J.-H.; Lee W.-C.; Chen C.-H.; Liu C.-J.; Huang Y.-H.; Wang C.-C.; Wang T.-E.; Chuang P.-H.; Dai C.-Y.; Hsu C.; Chen S.-C.; Hsieh C.-H.; Diagnosis Group, Systemic Therapy Group
臺大學術典藏 2021-08-03T07:10:52Z The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma Hung Y.-P.; YU-YUN SHAO; Hsu C.; Hsu C.-H.; Lee J.-M.; Yang M.-H.; Chao Y.
臺大學術典藏 2021-07-28T06:46:59Z Unexpected rapid progression of metastatic adenoid cystic carcinoma during treatment with imatinib mesylate CHING-HUNG LIN; Yen R.-F.; Jeng Y.-M.; Tzen C.-Y.; Hsu C.; Hong R.-L.
臺大學術典藏 2021-07-26T10:01:35Z Effect of Weighting Strategies on Taguchi-based Optimization of the Four-Stage Constant Current Charge Pattern Lee C;Hsu C;Hsu S;Jiang J.; Lee C; Hsu C; Hsu S; Jiang J.; JOE-AIR JIANG
臺大學術典藏 2021-07-20T03:15:17Z Spectrum of cancer patients receiving renal biopsy Chang F.-C.; Chen T.W.-W.; Huang T.T.-M.; Lin W.-C.; Liu J.-S.; Chiang W.-C.; Chen Y.-M.; Hsu C.; Yeh K.-H.; TZONG-SHINN CHU
臺大學術典藏 2021-07-12T08:46:27Z Predictors of bloodstream infection associated with permanently implantable venous port in solid cancer patients Chen I.C.; Hsu C.; Chen Y.C.; Chien S.F.; HSIANG-FONG KAO; Chang S.Y.; Hu F.C.; Yeh K.H.
臺大學術典藏 2021-07-12T08:46:26Z Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers HSIANG-FONG KAO; Chen I.-C.; Hsu C.; Chang S.-Y.; Chien S.-F.; Chen Y.-C.; Hu F.-C.; Yang J.C.-H.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2021-07-03T03:35:05Z A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial Hsu C.; Hsiung C.A.; Su I.-J.; Hwang W.-S.; Wang M.-C.; Lin S.-F.; Lin T.-H.; Hsiao H.-H.; Young J.-H.; Chang M.-C.; Liao Y.-M.; Li C.-C.; Wu H.-B.; Tien H.-F.; Chao T.-Y.; Liu T.-W.; Cheng A.-L.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:34:56Z Strategies to prevent hepatitis B virus reactivation in patients receiving immunosuppressive therapy Hsu C.; Wei S.-C.; Cheng A.-L.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:34:50Z Lamivudine and hepatitis B reactivation Hsu C.; Cheng A.-L.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:34:50Z Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway Chen K.-F.; Yeh P.-Y.; Hsu C.; Hsu C.-H.; Lu Y.-S.; Hsieh H.-P.; PEI-JER CHEN; Cheng A.-L.
臺大學術典藏 2021-07-03T03:34:48Z Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma Hsu C.-H.; Shen Y.-C.; Lin Z.-Z.; PEI-JER CHEN; Shao Y.-Y.; Ding Y.-H.; Hsu C.; Cheng A.-L.
臺大學術典藏 2021-07-03T03:34:46Z Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma Hsu C.-H.; Yang T.-S.; Hsu C.; Toh H.C.; Epstein R.J.; Hsiao L.-T.; PEI-JER CHEN; Lin Z.-Z.; Chao T.-Y.; Cheng A.-L.
臺大學術典藏 2021-07-03T03:34:45Z Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia: Experts'opinion PEI-JER CHEN; Furuse J.; Han K.-H.; Hsu C.; Lim H.-Y.; Moon H.; Qin S.; Ye S.-L.; Yeoh E.-M.; Yeo W.
臺大學術典藏 2021-07-03T03:34:40Z Eastern asian expert panel opinion: Designing clinical trials of molecular targeted therapy for hepatocellular carcinoma Yeo W.; PEI-JER CHEN; Furuse J.; Han K.-H.; Hsu C.; Lim H.-Y.; Moon H.; Qin S.; Yeoh E.-M.; Ye S.-L.
臺大學術典藏 2021-07-03T03:34:10Z Reply Hsu C.; PEI-JER CHEN; Cheng A.-L.
臺大學術典藏 2021-07-03T03:34:10Z Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study Hsu C.; Tsou H.-H.; Lin S.-J.; Wang M.-C.; Yao M.; Hwang W.-L.; Kao W.-Y.; Chiu C.-F.; Lin S.-F.; Lin J.; Chang C.-S.; Tien H.-F.; Liu T.-W.; PEI-JER CHEN; Cheng A.-L.

顯示項目 266-290 / 881 (共36頁)
<< < 6 7 8 9 10 11 12 13 14 15 > >>
每頁顯示[10|25|50]項目